These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19710515)

  • 1. Hitting the mucosal road in tolerance induction.
    Wiedermann U
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():63-72; discussion 72-74, 251-7. PubMed ID: 19710515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities.
    Wild C; Wallner M; Hufnagl K; Fuchs H; Hoffmann-Sommergruber K; Breiteneder H; Scheiner O; Ferreira F; Wiedermann U
    Allergy; 2007 Jan; 62(1):33-41. PubMed ID: 17156339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
    von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
    Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches in treating food allergy using allergens.
    Rancé F
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():157-63; discussion 164-7, 251-7. PubMed ID: 19710521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of type I allergy using recombinant allergens.
    Herz U; Renz H; Wiedermann U
    Methods; 2004 Mar; 32(3):271-80. PubMed ID: 14962762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of antigen-specific immunotherapy of allergy.
    Valenta R
    Nat Rev Immunol; 2002 Jun; 2(6):446-53. PubMed ID: 12093011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual vaccines based on wild-type recombinant allergens.
    Van Overtvelt L; Razafindratsita A; St-Lu N; Didierlaurent A; Batard T; Lombardi V; Martin E; Moingeon P
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):247-9. PubMed ID: 17124785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European LABDEL project and its relevance to the prevention and treatment of allergies.
    Daniel C; Repa A; Mercenier A; Wiedermann U; Wells J
    Allergy; 2007 Nov; 62(11):1237-42. PubMed ID: 17919137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy.
    Möbs C; Slotosch C; Löffler H; Pfutzner W; Hertl M
    Int Arch Allergy Immunol; 2008; 147(3):171-8. PubMed ID: 18594146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of allergy: avoiding risk or providing protection?
    Hamelmann E; Beyer K; Gruber C; Lau S; Matricardi PM; Nickel R; Niggemann B; Wahn U
    Clin Exp Allergy; 2008 Feb; 38(2):233-45. PubMed ID: 18081883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological mechanisms of sublingual allergen-specific immunotherapy.
    Novak N; Bieber T; Allam JP
    Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of probiotic bacteria for prevention and therapy of allergic diseases: studies in mouse model of allergic sensitization.
    Di Felice G; Barletta B; Butteroni C; Corinti S; Tinghino R; Colombo P; Boirivant M
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S130-2. PubMed ID: 18806704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvants and vector systems for allergy vaccines.
    Moingeon P; Lombardi V; Saint-Lu N; Tourdot S; Bodo V; Mascarell L
    Immunol Allergy Clin North Am; 2011 May; 31(2):407-19, xii. PubMed ID: 21530828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for converting allergens into hypoallergenic vaccine candidates.
    Vrtala S; Focke-Tejkl M; Swoboda I; Kraft D; Valenta R
    Methods; 2004 Mar; 32(3):313-20. PubMed ID: 14962766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tolerance, food allergy, and immunotherapy: implications for future treatment.
    Burks AW; Laubach S; Jones SM
    J Allergy Clin Immunol; 2008 Jun; 121(6):1344-50. PubMed ID: 18410959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular approaches for new vaccines against allergy.
    Niederberger V; Valenta R
    Expert Rev Vaccines; 2006 Feb; 5(1):103-10. PubMed ID: 16451112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-specific immunotherapy.
    Niederberger V
    Immunol Lett; 2009 Feb; 122(2):131-3. PubMed ID: 19100771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.